Physician profile
Vamsidhar Chavakula
NPI 1508124918
$88,112.62
in general payments reported to CMS, 2019-2025
30 companies · $26K in 2025
The $26K reported for 2025 was more than what 91% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,967 · 2020: $129 · 2021: $3,476 · 2022: $4,432 · 2023: $27K · 2024: $25K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $60K · Food and Beverage: $12K · Travel and Lodging: $6,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $60,035.00 |
| Food and Beverage | $11,888.00 |
| Travel and Lodging | $6,186.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyocera Medical Technologies, INC. | $59,990.70 | 2022-2025 | |
| Medtronic, INC. | $7,300.74 | 2021-2025 | Unid_pass, Mazor X System, Atlantis Anterior Cervical Plate System |
| Globus Medical, INC. | $3,751.97 | 2022-2025 | Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System, Alif Instruments (Universal) |
| Depuy Synthes Sales INC. | $2,261.02 | 2020-2025 | Teligen, Vivigen Mis Delivery System |
| Abbott Laboratories | $2,090.17 | 2022-2025 | Infinity, Proclaim |
| Cerapedics INC. | $1,743.52 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Insightec,INC | $1,547.16 | 2021-2025 | Exablate |
| Boston Scientific Corporation | $1,428.79 | 2021-2025 | General - Dbs, Vercise, Wavewriter Alpha Prime 16 |
| Medical Device Business Services, INC. | $1,161.06 | 2021-2024 | Conduit, Spine & Trauma 3d Navigation |
| Si-Bone, INC. | $1,085.52 | 2019-2022 | |
| Aurora Spine, INC. | $1,000.00 | 2025 | Mega Plus Mis Spine System |
| Medtronic USA, INC. | $986.59 | 2019-2020 | |
| Orthofix Medical, INC. | $923.56 | 2021-2025 | Regatta Lateral System, Shoreline Rt, Osteostrand |
| Stryker Corporation | $883.84 | 2022-2024 | Sonopet Iq, Core, N/A |
| Brainlab, INC. | $703.55 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $180.15 | 2024-2025 | Cusa Clarity, Codman Certas, Codman Hakim |
| Alphatec Spine, INC | $154.03 | 2022-2023 | Other - Miscellaneous |
| Aesculap, INC. | $149.36 | 2024 | Progav 2.0 |
| Nevro Corp. | $132.86 | 2023 | Senza |
| Monteris Medical Corporation | $125.93 | 2020-2024 | Neuroblate |
| Intrinsic Therapeutics | $82.43 | 2023-2025 | Barricaid Acd (Annular Closure Device) |
| Kuros Biosciences USA, INC | $79.41 | 2024 | Magnetos |
| Acera Surgical, INC. | $74.14 | 2025 | Restrata Wound Matrix |
| Nuvasive, INC. | $69.28 | 2021 | |
| Gt Medical Technologies, INC | $50.98 | 2021 | |
| Neuropace, INC. | $33.96 | 2023-2024 | |
| Kerecis Limited | $32.64 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Icotec Medical INC. | $32.40 | 2023 | Icotec Blackarmor Spine System |
| Elevate Surgical Co | $31.86 | 2024 | |
| Degen Medical, INC. | $25.00 | 2025 | Alif |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vamsidhar Chavakula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.